Recce Pharmaceuticals (ASX:RCE, FSE:R9Q) is a Sydney-based company fighting the battle against superbugs, with a legitimate chance of succeeding if the data to date is any guide. Bacterial infections have become an increasing problem as bacteria develop resistance to conventional antibiotics causing life threatening conditions such as sepsis. There is an urgent need for treatments…